History | Tofacitinib for moderately to severely active ulcerative colitis | Guidance | NICE

History

Documents created during the development process.

Expected publication

Equality Impact Assessment (Guidance development) (PDF 220 KB)

Published:

28 November 2018

Final appraisal determination

Final appraisal determination
Final appraisal determination document (PDF 347 KB)

Published:

01 October 2018
Committee papers (PDF 16.93 MB)

Published:

01 October 2018
Public committee slides - clinical (PDF 1.41 MB)

Published:

01 October 2018
Public committee slides - cost (PDF 1.33 MB)

Published:

01 October 2018

Invitation to participate

Final scope (PDF 224 KB)

Published:

09 March 2018
Final matrix (PDF 255 KB)

Published:

09 March 2018
NICE's response to comments on the draft scope and provisional matrix (PDF 296 KB)

Published:

09 March 2018
Equality impact assessment (Scoping) (PDF 174 KB)

Published:

09 March 2018

Consultation on suggested remit, draft scope and provisional matrix of consultees and commentators

Draft matrix pre referral (PDF 266 KB)

Published:

27 September 2017
Draft scope pre referral (PDF 315 KB)

Published:

27 September 2017